Head to Head Comparison: Spectral AI (NASDAQ:MDAI) & Sintx Technologies (NASDAQ:SINT)

Spectral AI (NASDAQ:MDAI) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.

Earnings and Valuation

This table compares Spectral AI and Sintx Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65 million	2.69	-$7.57 million	($0.35)	-4.69
Sintx Technologies	$1.02 million	7.33	-$10.36 million	($4.91)	-0.35

Spectral AI has higher revenue and earnings than Sintx Technologies. Spectral AI is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Spectral AI and Sintx Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Sintx Technologies	-848.20%	-354.44%	-115.37%

Analyst Recommendations

This is a summary of current recommendations and price targets for Spectral AI and Sintx Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1	0	1	1	2.67
Sintx Technologies	1	0	3	0	2.50

Spectral AI currently has a consensus price target of $4.00, suggesting a potential upside of 143.90%. Sintx Technologies has a consensus price target of $9.33, suggesting a potential upside of 439.50%. Given Sintx Technologies’ higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Spectral AI.

Insider & Institutional Ownership

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Comparatively, 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Spectral AI beats Sintx Technologies on 10 of the 14 factors compared between the two stocks.

About Spectral AI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.